DHL Group is expanding its pharmaceutical logistics infrastructure in Singapore with new and enlarged temperature-controlled facilities at Changi Airport.
The investment includes a second DHL Supply Chain Pharma Hub, a new DHL Global Forwarding Singapore Coldchain Hub and a dedicated GDP-compliant healthcare handling and storage area at DHL Express’ South Asia Hub.
DHL Global Forwarding is reportedly investing S$22 million (€15m) in the Singapore Coldchain Hub at Changi Nexus One, within Changi Airport’s Free Trade Zone. Expected to launch in late 2027, the 3,047m² facility will provide temperature-controlled handling at 2°C to 8°C and 15°C to 25°C for pharmaceuticals, vaccines and biologics.
Meanwhile, DHL Supply Chain is investing S$7m (€5m) in Pharma Hub 2, an 8,000m² temperature-controlled facility offering around 7,680 pallet positions. Together, the 3PL’s two Singapore pharma hubs will provide around 16,000m² of space and 12,000 pallet positions. The new facility is expected to begin operations in the first half of 2027.
DHL Express has also introduced a 20m² GDP-compliant area at its South Asia Hub at Changi Airport for pharmaceutical shipments that require temperatures of 15°C to 25°C. DHL said it is the first GDP-compliant healthcare logistics space within a DHL Express facility globally.
The Singapore investments form part of DHL Group’s wider €2bn global Life Sciences & Healthcare investment programme announced in 2025, of which €500m has been earmarked for the Asia-Pacific region.
IntraLogisteX Singapore connects providers of effective supply chain & logistics solutions with supply chain & manufacturing professionals.
